Cargando…

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio‐oncology units in Europe and a grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anker, Markus S., Hadzibegovic, Sara, Lena, Alessia, Belenkov, Yury, Bergler‐Klein, Jutta, de Boer, Rudolf A., Farmakis, Dimitrios, von Haehling, Stephan, Iakobishvili, Zaza, Maack, Christoph, Pudil, Radek, Skouri, Hadi, Cohen‐Solal, Alain, Tocchetti, Carlo G., Coats, Andrew J.S., Seferović, Petar M., Lyon, Alexander R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	ESC and HFA Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989292/ https://www.ncbi.nlm.nih.gov/pubmed/31884717 http://dx.doi.org/10.1002/ehf2.12551

Ejemplares similares

Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device‐supported patients for the non‐left ventricular assist device specialist healthcare provider: Part 2: at the emergency department
por: Milicic, Davor, et al.
Publicado: (2021)

Modern‐day cardio‐oncology: a report from the ‘Heart Failure and World Congress on Acute Heart Failure 2018’
por: Anker, Markus S., et al.
Publicado: (2018)

Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology
por: Lancellotti, Patrizio, et al.
Publicado: (2017)

HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge
por: Gustafsson, Finn, et al.
Publicado: (2021)

HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings in the community
por: Ben Avraham, Binyamin, et al.
Publicado: (2021)

Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies
por: Jorbenadze, Ana, et al.
Publicado: (2021)

Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice
por: Richter, Dimitrios, et al.
Publicado: (2021)

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
por: de Boer, Rudolf A., et al.
Publicado: (2019)

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2022)

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)

The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics
por: Shanmugam, Nesan
Publicado: (2022)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

New Trial Evidence on Heart Failure: Highlights from the European Society of Cardiology Congress 2021
por: Ferrannini, Giulia, et al.
Publicado: (2022)

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
por: Lyon, Alexander R., et al.
Publicado: (2020)

Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial
por: Zannad, Faiez, et al.
Publicado: (2015)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Heart failure in the last year: progress and perspective
por: Tomasoni, Daniela, et al.
Publicado: (2020)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study(†)
por: Budera, Petr, et al.
Publicado: (2012)

A year in heart failure: an update of recent findings
por: Stretti, Lorenzo, et al.
Publicado: (2021)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Metabolic disorders in heart failure and cancer
por: Lena, Alessia, et al.
Publicado: (2018)

Expect the Unexpected in the Medical Treatment of Heart Failure with Reduced Ejection Fraction: between Scientific Evidence and Clinical Wisdom
por: Seferovic, Petar M., et al.
Publicado: (2021)

Takotsubo syndrome in Heart Failure and World Congress on Acute Heart Failure 2019: highlights from the experts
por: Keramida, Kalliopi, et al.
Publicado: (2020)

ESC Heart Failure increases its impact factor
por: Anker, Markus S., et al.
Publicado: (2020)

Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly
por: Milinković, Ivan, et al.
Publicado: (2022)

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD)
por: Boggon, Rachael, et al.
Publicado: (2011)

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
por: Goto, Shinya, et al.
Publicado: (2010)

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: James, Stefan, et al.
Publicado: (2010)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium(†)
por: Riegger, Julia, et al.
Publicado: (2016)

Universality of sex differences in cardiovascular outcomes: where do we go from here?
por: Miller, Virginia M
Publicado: (2020)

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
por: Maas, Angela H E M, et al.
Publicado: (2021)

2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
por: Dan, Gheorghe-Andrei
Publicado: (2021)

European Society of Cardiology Highlights: Late-breaking Science MINOCA/ANOCA
por: Ong, Peter, et al.
Publicado: (2022)

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019)

Heart Failure and Importance of Collaboration of Professional Organizations: The Role of the Heart Failure Association of the European Society of Cardiology and Its Committee on National Heart Failure Societies
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2015)

The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians
por: Anker, Markus S., et al.
Publicado: (2020)

Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry
por: Kapłon‐Cieślicka, Agnieszka, et al.
Publicado: (2020)

Heart Failure 2013
por: Giamouzis, Gregory, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qa1eal5csieftqb1ktv8i3bhv1